In June, preliminary results from a large, randomized study in the United Kingdom found that a low-dose regimen Remdesivir (Veklury®) is provisionally registered by the Therapeutic Goods Administration for use in Australia for the treatment of COVID-19
In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at The drug became a standard clinical weapon against severe COVID-19 worldwide after a U
Remdesivir and Dexamethasone represent the cornerstone of therapy for critically ill patients with acute hypoxemic respiratory failure caused by Coronavirus
M
Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study Simon B
Dexamethasone and other corticosteroids may be harmful if given for less severe COVID-19 infection
Seven of them received a 3-day course to prevent progression to lower respiratory tract
However, after experiencing persistent cough, fever, and hypoxemia (oxygen saturation, 92%), he was admitted to the hospital on day 25 of illness